Bio-Techne Executive and Leadership Team

James Hippel, the Executive Vice President & Chief Financial Officer at Bio-Techne, directs the financial strategy and capital allocation for the organization. Overseeing fiscal planning, reporting, and investor relations, the Executive Vice President & Chief Financial Officer ensures the financial health required to sustain long-term investment in research and development. This leadership role involves managing the economic impact of global manufacturing operations and supporting the expansion of the company's diagnostic product lines. By optimizing the balance sheet and maintaining rigorous internal controls, James Hippel provides the stability needed for sustained market growth. Hippel collaborates with the executive team to evaluate strategic acquisitions and resource distribution across diverse business segments. Through disciplined financial oversight, the Executive Vice President & Chief Financial Officer secures the resources necessary to advance the company's mission of providing critical tools for the clinical diagnostic and research communities.

Steve Crouse, the President, Diagnostics & Spatial Biology Segment at Bio-Techne, directs the development and commercialization of advanced diagnostic tools and spatial biology platforms. Overseeing the segment's product lifecycle, the President, Diagnostics & Spatial Biology Segment ensures that clinical diagnostic communities receive the precise reagents and instruments needed for accurate disease identification. This leadership role involves expanding the market reach of spatial biology solutions to support complex research into biological processes. By driving innovation in diagnostic testing, Steve Crouse enhances the company's impact on clinical outcomes. Crouse coordinates with research teams to translate scientific discoveries into scalable commercial products. Through the strategic management of this segment, the President, Diagnostics & Spatial Biology Segment supports the company's commitment to providing the means for accurate clinical tests and diagnoses, ultimately improving the understanding of disease progression on a global scale.

Will Geist, the President, Protein Sciences Segment at Bio-Techne, directs the production and distribution of bioactive reagents essential for protein research. Overseeing the segment's manufacturing and innovation strategies, the President, Protein Sciences Segment ensures that researchers have access to high-quality tools for investigating biological processes. This role involves managing the supply chain and technical support for protein-based research initiatives across international markets. By optimizing the development of reagents, Will Geist supports drug discovery efforts and fundamental scientific investigations. Geist collaborates with internal teams to maintain the high standards required for clinical and research applications. Through the strategic focus on protein sciences, the President, Protein Sciences Segment drives the company's ability to provide the foundational materials necessary for modern biological research, ensuring that the organization remains a trusted partner for the global scientific community.

Gary Latham, the Vice President & Chief Technology Officer at Bio-Techne, directs the research and development roadmap for innovative life science tools. Overseeing the integration of advanced bioactive reagents into clinical workflows, the Vice President & Chief Technology Officer ensures that technical capabilities align with the evolving needs of the global research community. This leadership role involves architecting scalable solutions for drug discovery and diagnostic testing across North American and European markets. By fostering collaboration between engineering teams and scientific researchers, Gary Latham accelerates the deployment of high-impact technologies. Latham maintains a focus on long-term technical viability, ensuring that the product portfolio remains at the forefront of biological investigation. Through rigorous oversight of technical infrastructure, the Vice President & Chief Technology Officer drives the company's mission to provide precise, reliable data for complex scientific challenges.

Cheryl Bethune, the Senior Vice President & Chief Human Resources Officer at Bio-Techne, architects the organizational culture and talent acquisition strategies necessary for a global life sciences leader. Managing the human capital lifecycle, the Senior Vice President & Chief Human Resources Officer ensures that the workforce possesses the specialized expertise required to support complex drug discovery and clinical diagnostic initiatives. This role involves designing comprehensive development programs that cultivate scientific talent across international operations. By aligning personnel objectives with corporate growth targets, Cheryl Bethune strengthens the internal capacity for innovation. Bethune prioritizes the retention of high-performing teams, creating an environment conducive to scientific breakthroughs. Through the implementation of robust performance management systems, the Senior Vice President & Chief Human Resources Officer optimizes organizational efficiency, ensuring that the company maintains a competitive edge in the global life sciences market.

Laurie Gilman, the Vice President, Finance Operations & Chief of Staff at Bio-Techne, executes the operational alignment between financial performance and corporate strategy. Overseeing the integration of finance operations with daily business activities, the Vice President, Finance Operations & Chief of Staff ensures that resources flow efficiently toward high-priority research and diagnostic projects. This role involves coordinating cross-functional initiatives that streamline internal processes and enhance organizational agility. By managing the executive office's strategic agenda, Laurie Gilman facilitates communication between leadership and operational departments. Gilman monitors key performance indicators to ensure that the company meets its objectives in the competitive life sciences sector. Through the synchronization of financial data and operational execution, the Vice President, Finance Operations & Chief of Staff drives the efficiency required to support the company's global mission of providing innovative tools for scientific investigation.